Ospedale Versilia

Recent papers from Ospedale Versilia

1. SGLT2 inhibitor dapagliflozin attenuates cardiomyocyte injury and inflammation induced by PI3Kα-selective inhibitor alpelisib and fulvestrant under hyperglycemiaEuropean Heart Journal · 2026
2. Pleiotropic effects of canagliflozin and dapagliflozin in cadio-oncology: a novel strategy to balance antitumor efficacy and cardiotoxicity in HER2-positive breast cancer therapyEuropean Heart Journal · 2026
3. Pulmonary embolism mortality has declined over the last twenty years, reflecting true prognostic improvement across ESC risk categoriesEuropean Heart Journal · 2026
4. Multicenter validation of the TELOSplus score for 30-day pulmonary embolism–related death in normotensive patientsEuropean Heart Journal · 2026
5. Derivation and validation of the BLEEPE score for risk stratification of major bleeding in patients with acute pulmonary embolismEuropean Heart Journal · 2026
6. Kidney Involvement in Primary Sjögren Syndrome: Focus on Tubulointerstitial NephritisMedicina · 2026
7. Triple immune checkpoint blockade induces immune-mediated cardiomyocyte injury: translational implications for cardio-oncology surveillanceEuropean Heart Journal Supplements · 2026
8. To stop or not to stop: that is the question - resuming immunotherapy in cancer patients on immune checkpoint inhibitors treatment following atherosclerosis-related acute cardiovascular eventsEuropean Heart Journal Supplements · 2026
9. SGLT2 inhibitor dapagliflozin attenuates pro-oxidative cardiomyocyte injury induced by PI3K selective inhibitor alpelisib and fulvestrant under hyperglycemiaEuropean Heart Journal Supplements · 2026
10. Metabolic targeting with SGLT2 inhibitors differentially modulates cardiotoxicity and antitumor activity during HER2-targeted breast cancer therapyEuropean Heart Journal Supplements · 2026
11. GLP1 receptor agonism attenuates anthracycline and HER2 targeted therapy induced cardiac dysfunction and systemic inflammation in non-diabetic modelsEuropean Heart Journal Supplements · 2026
12. Remnant cholesterol and cardiovascular risk in maintenance haemodialysisClinical Kidney Journal · 2026
13. Contemporary invasive management and in-hospital outcomes of acute myocardial infarction in patients with active or prior cancer: insights from the EYESHOT-2 registryInternational Journal of Cardiology · 2026
14. Baricitinib versus ritlecitinib for severe alopecia areata: A 24‐week real‐world studyJournal of the European Academy of Dermatology and Venereology · 2026
15. The New Cardio-Oncology Frontier in Hematologic Cancers: Cardiovascular Toxicities of CAR-T Cells and Bispecific T-Cell EngagersJournal of Clinical Medicine · 2026
16. Real‐world outcomes of venetoclax plus hypomethylating agents in unfit acute myeloid leukaemia: Results of the GIMEMA AML2320 trialBritish Journal of Haematology · 2026
17. Long-term cardiometabolic health in people born after assisted reproductive technology: a multi-cohort analysisENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) · 2023
18. Medical error in neonatal units: an Italian survey on national frequency and types of error˜The œItalian Journal of Pediatrics/Italian journal of pediatrics · 2026
19. Coronary Aneurysmal and Ectatic Disease: Cath-Lab Diagnosis and Contemporary Interventional ManagementThe American Journal of Cardiology · 2026
20. Subperiosteal Digitally Manufactured Implant Combined with Guided Pterygoid Fixation for Rehabilitation of the Severely Atrophic MaxillaOral · 2026